Laxido Junior (Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Macrogol 3350)

• Laxido Junior, an osmotic laxative, is used to manage pediatric constipation and related functional bowel disorders.
• Constipation in children: softens stool and facilitates regular bowel movements.
• Functional constipation: improves stool consistency and reduces abdominal discomfort.
• Chronic constipation: provides long‑term relief by maintaining intestinal hydration.

• Macrogol 3350 acts as a high‑molecular‑weight polymer that remains largely unabsorbed in the gastrointestinal tract. It exerts an osmotic effect by retaining water within the intestinal lumen, thereby increasing stool water content, softening the fecal mass, and stimulating peristalsis. The accompanying electrolytes (sodium hydrogen carbonate, potassium chloride, sodium chloride) help preserve electrolyte balance during the laxation process and supporting overall bowel health.

Laxido Junior may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Abdominal bloating
• Flatulence
• Nausea
• Mild diarrhea
• Abdominal cramps
• Increased thirst

Serious or Rare Side Effects

• Severe dehydration
• Electrolyte imbalance
• Allergic reaction (rash, itching, swelling)
• Severe abdominal pain
• Rectal bleeding
• Anaphylaxis

• When using Laxido Junior, certain precautions should be observed to ensure safety and effectiveness.
• Dose adjustment: tailor the dose to the child's age and weight under medical supervision.
• Electrolyte monitoring: assess serum electrolytes during prolonged therapy or in patients with renal disease.
• Renal impairment: use cautiously in children with compromised kidney function.
• Use in children: ensure the appropriate pediatric formulation and dosage are applied.
• Avoid concurrent use with other laxatives: prevent additive osmotic load.
• Store at ambient temperature: keep in the original packaging, protect from moisture.

Laxido Junior can interact with other medicines; some combinations should be avoided while others require monitoring.

Major Interactions (Avoid)

• Concurrent use with high‑dose electrolyte solutions: risk of electrolyte overload.
• Co‑administration with mineral oil: may reduce efficacy of both agents.

Moderate Interactions (Monitor Closely)

• Diuretics: monitor electrolytes due to additive fluid loss.
• Anticholinergic drugs: may diminish laxative effect.
• Other osmotic laxatives (e.g., lactulose): increase risk of diarrhea and electrolyte disturbance.